Emergence of space tourism highlights risks in the earth’s orbit

The accelerated shift to intangible assets and how to protect them

Over the past decades, companies have experienced a massive shift from tangible to intangible assets in their balance sheet exposures, which needs to be reflected in their risk management strategies.

Preparing the economy for the impact of the upcoming UK Environment Bill

As the UK Government develops a new governance system on environmental issues, businesses need to consider how their processes may need to change to ensure that they remain compliant and to avoid potential fines.

New safety regulation to address tall building risks post Grenfell

A new Building Safety Bill in the UK turns the recommendations from Dame Judith Hackitt thorough independent review of building regulations and fire safety into legislation. It will be formally introduced in the House of Commons in 2021, marking four years since the tragic fire at Grenfell Tower that claimed 72 lives.

Businesses mull options for Covid-19 vaccine approach

As the Covid-19 vaccine rollout progresses worldwide, businesses are debating how this will affect the return to the office as well as the health and safety measures that will be required.

Regulatory requirements trigger fresh ESG push

As the world digests the consequences of the pandemic, one of the changes coming to the fore is a new, stronger focus on environmental, social, and governance (ESG) policies. It is in the interest of companies to follow strict ESG standards, as this can help reduce their risk exposure and insurance needs. Plus, governments are now putting in place regulatory frameworks to standardise ESG reporting protocols and accelerate change.

Protecting a company’s intangible assets

A company's fixed assets such as laptops, plant and equipment are usually secured, guarded and insured. While this remains important, intangible assets such as brands, confidential information, or patents are usually much more valuable, but also more difficult to protect.

Risky business: Developing a COVID-19 drug

The exceptional pressure on the pharma sector to find a drug that ends the COVID-19 crisis has created a race to identify effective treatments under unprecedented circumstances, further increasing the traditionally high risk involved in such undertakings.

Investors push ESG up the corporate agenda

A growing number of investors believe that companies with strong environmental, social and governance (ESG) policies and responsible governance are more resilient and financially successful. The COVID-19 pandemic may be a case in point.